4//SEC Filing
Sheng Morgan 4
Accession 0001209191-19-057001
CIK 0001714798other
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 5:35 PM ET
Size
5.4 KB
Accession
0001209191-19-057001
Insider Transaction Report
Form 4
Sheng Morgan
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-11-15+20,000→ 20,000 totalExercise: $10.62Exp: 2029-11-15→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The shares underlying the option will vest in 36 equal monthly installments beginning on December 15, 2019, subject to the Reporting Person's continuous service to the Issuer on each such date.
Documents
Issuer
Prevail Therapeutics Inc.
CIK 0001714798
Entity typeother
Related Parties
1- filerCIK 0001793833
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 5:35 PM ET
- Size
- 5.4 KB